Dear Subscriber,
Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
New Target For Fight Against Common Type Of Breast Cancer: Brk
http://www.medicalnewstoday.com/articles/119414.php
Anew promising enzyme target for a specific type of breast cancer, Brk,has been identified in research published on August 21, 2008 inthe <i>Proceedings of the National Academy of Sciences</i>(PNAS.
Breastfeeding Could Reduce Risk Of Aggressive Form Of Breast Cancer That Disproportionately Affects Black, Younger Women
http://www.medicalnewstoday.com/articles/119409.php
Breastfeeding for at least six months might lower the risk of developing so-called "triple negative" breast cancer, an aggressive form of the disease that is more common in black and younger women, according to a study published on Monday in the journal <cite>Cancer</cite>, the <a href="http://seattlepi.
American Medical Student Association Academy Provides Leadership Training For Tomorrow's Physicians
http://www.medicalnewstoday.com/articles/119328.php
The American Medical Student Association (AMSA), the nation's oldest and largest, independent association for physicians-in-training, announces the commencement of AMSA Academy, a training ground for physician leaders.
----------------------------------------------
** CANCER / ONCOLOGY News **
Gene Found For Rare And Deadly Chidhood Cancer Neuroblastoma
http://www.medicalnewstoday.com/articles/119435.php
US scientists have found that mutations of a gene called anaplastic lymphoma kinase (ALK) were behind most incidences of hereditary neuroblastoma, a rare and deadly childhood cancer, and they also discovered that the same mutations played an important role in high risk forms of non-inherited incidences of the disease, which are more common.
Skin Cancer May Increase Risk Of Other Cancers
http://www.medicalnewstoday.com/articles/119420.php
A new study from the US suggests that people who have had nonmelanoma skin cancer (NMSC) may be at increased risk of developing other cancers, including those that affect other parts of the body.
New Target For Fight Against Common Type Of Breast Cancer: Brk
http://www.medicalnewstoday.com/articles/119414.php
Anew promising enzyme target for a specific type of breast cancer, Brk,has been identified in research published on August 21, 2008 inthe <i>Proceedings of the National Academy of Sciences</i>(PNAS.
Robotic Kidney Removal Performed In Michigan
http://www.medicalnewstoday.com/articles/119413.php
Adiseased kidney has been surgically extracted using a minimallyinvasive technique that utilizes 3D robotics, at the Henry FordHospital, the first surgery of its kind in Michigan. About55,000 people are diagnosed with kidney cancer every year.
Singer Sandi Thom Ages 30 Years To Warn Young People About Sunbeds
http://www.medicalnewstoday.com/articles/119380.php
Singer/songwriter Sandi Thom, aged 27, has teamed up with Cancer Research UK to warn youngsters about the dangers of using sunbeds. The charity has today published shocking images of how Sandi could look in thirty years time through overexposure to UV rays, which in some sunbeds can be 10-15 times higher than those of the midday sun.
Cancer Patients Are Kept In The Dark Surrounding Treatments Awaiting NICE Approval, UK
http://www.medicalnewstoday.com/articles/119367.php
One in four doctors choose not to discuss life extending cancer treatments that are awaiting NICE (National Institute for Health and Clinical Excellence) approval with their patients. The research, commissioned by Myeloma UK, also revealed that 75 percent of doctors receive no guidance on discussing the availability of these treatments with their patients and a fifth of doctors believe that prescribing new treatment options for myeloma is completely 'out of their hands'.
Flower Power: Tel Aviv University Researchers Are Combatting Cancer With A Jasmine-Based Drug
http://www.medicalnewstoday.com/articles/119352.php
Could a substance from the jasmine flower hold the key to an effective new therapy to treat cancer?Prof. Eliezer Flescher of The Sackler Faculty of Medicine, Tel Aviv University thinks so. He and his colleagues have developed an anti-cancer drug based on a decade of research into the commercial applications of the compound Jasmonate, a synthetic compound derived from the flower itself.
Radiation Oncology Institute Launched, Receives $5 Million Grant
http://www.medicalnewstoday.com/articles/119329.php
To prepare the specialty of radiation oncology for the future, the American Society for Therapeutic Radiology and Oncology has donated $5 million to formally launch the Radiation Oncology Institute.
American Medical Student Association Academy Provides Leadership Training For Tomorrow's Physicians
http://www.medicalnewstoday.com/articles/119328.php
The American Medical Student Association (AMSA), the nation's oldest and largest, independent association for physicians-in-training, announces the commencement of AMSA Academy, a training ground for physician leaders.
Viral Cancers - Sylvester Researcher Discovers Key Molecule That Triggers Immune Response
http://www.medicalnewstoday.com/articles/119317.php
Scientists have long been working to uncover the mystery of what sparks the body's immune system. Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have discovered a key component in that puzzle: a new molecule that recognizes a virus infection and initiates the signal to generate an immune system response.
Global Survey Highlights Need For Cancer Prevention Campaigns To Correct Misbeliefs
http://www.medicalnewstoday.com/articles/119304.php
Many people hold mistaken beliefs about what causes cancer, tending to inflate the threat from environmental factors that have relatively little impact while minimizing the hazards of behaviours well established as cancer risk factors, according to the first global survey on the topic.
Genmab Has Announced Plans To Begin Four Studies Of Ofatumumab In Chronic Lymphocytic Leukemia And Non-Hodgkin's Lymphoma
http://www.medicalnewstoday.com/articles/119301.php
Genmab A/S (OMX: GEN) announced plans to begin four studies of ofatumumab in chronic lymphocytic leukemia (CLL) and follicular non-Hodgkin's lymphoma (NHL) this year."Genmab and GSK have worked diligently to expand the ofatumumab development program to maximize the value of the antibody for patients and shareholders since our collaboration began," said Lisa N.
Asian-American/Pacific Islanders Have Higher Survival Rates Than Others For Gastric Cancers, Study Finds
http://www.medicalnewstoday.com/articles/119300.php
Asian-American/Pacific Islanders with early-stage stomach cancers have an overall median survival rate that is higher than those of other races or ethnicities, according to new research, <a href="http://www.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
No news for this category today.
----------------------------------------------
** COLORECTAL CANCER News **
No Link Found Between Diverticular Disease And Consumption Of Nuts, Seeds, And Corn
http://www.medicalnewstoday.com/articles/119224.php
A new study published in the August 27 issue of <i>JAMA </i>reportsgood news for men who enjoy nuts, corn, or popcorn. Researchersstudying a large cohort of men have found that consumption of thesefoods does not increase the risk of diverticulosis or diverticularcomplications - a conclusion that is contrary to common beliefs.
----------------------------------------------
** LUNG CANCER News **
No news for this category today.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
Cancer Patients Are Kept In The Dark Surrounding Treatments Awaiting NICE Approval, UK
http://www.medicalnewstoday.com/articles/119367.php
One in four doctors choose not to discuss life extending cancer treatments that are awaiting NICE (National Institute for Health and Clinical Excellence) approval with their patients. The research, commissioned by Myeloma UK, also revealed that 75 percent of doctors receive no guidance on discussing the availability of these treatments with their patients and a fifth of doctors believe that prescribing new treatment options for myeloma is completely 'out of their hands'.
Vidaza, Only Agent To Extend Survival In Patients With Higher-Risk Myelodysplastic Syndromes
http://www.medicalnewstoday.com/articles/119307.php
The Myelodysplastic Syndromes (MDS) Foundation supports the decision by the U.S. Food & Drug Administration (FDA) to extend the label for VIDAZA (azacitidine) to include data from the AZA-001 clinical trial.
Genmab Has Announced Plans To Begin Four Studies Of Ofatumumab In Chronic Lymphocytic Leukemia And Non-Hodgkin's Lymphoma
http://www.medicalnewstoday.com/articles/119301.php
Genmab A/S (OMX: GEN) announced plans to begin four studies of ofatumumab in chronic lymphocytic leukemia (CLL) and follicular non-Hodgkin's lymphoma (NHL) this year."Genmab and GSK have worked diligently to expand the ofatumumab development program to maximize the value of the antibody for patients and shareholders since our collaboration began," said Lisa N.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
Large Studies Needed To Further Confirm Prostate Cancer Drug Abiraterone
http://www.medicalnewstoday.com/articles/119321.php
Larger trials are needed to further examine and confirm the early findings on the experimental drug abiraterone acetate (CB7630). Researcher Dr. Johann de Bono, from the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust in the UK, who led two ongoing clinical trials of CB7630, said larger studies are necessary to find out the efficacy of the drug.
Urodynamix Awarded NRC-IRAP Support For New Prostate Cancer Detection Technology, Canada
http://www.medicalnewstoday.com/articles/119313.php
Urodynamix Technologies Ltd. (TSX-V:URO) announced that it has received a non-refundable financial contribution from the National Research Council Canada Industrial Research Assistance Program (NRC-IRAP) to help accelerate the development and commercialization of new NIRS technology for the detection of prostate cancer during the digital rectal examination, or DRE.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
